A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. The researchers report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/efficacy-and-effectiveness-rvsv-vectored-vaccine-expressing-ebola-surface
[2] http://admin.indiaenvironmentportal.org.in/category/author/ana-maria-henao-restrepo
[3] http://admin.indiaenvironmentportal.org.in/category/author/ira-m-longini-0
[4] http://admin.indiaenvironmentportal.org.in/category/author/matthias-egger-et-al
[5] http://admin.indiaenvironmentportal.org.in/category/journal/lancet
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ebola-virus-disease-ebola-hemorrhagic-fever
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/guinea
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination